Evidence map›Paper›PMID 36819173›Full record

ArticleEJHaem2023

Germline

Cécile Liu, Paola Ballerini, Guillaume Nguyen, Zoia Mincheva, Bruno Copin, Boutheina Bouslama, Guy Leverger, Arnaud Petit, Rémi Favier, Hélène Lapillonne and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Observational
  2. Review
  3. GermlineEJHaem · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Cécile LiuSorbonne University, AP-HP, Paediatric Haematology and Oncology Department Armand-Trousseau Hospital Paris France.ORCID https://orcid.org/0000-0002-0005-5357
Paola BalleriniSorbonne University, AP-HP, Laboratory of Haematology Armand-Trousseau Hospital Paris France.
Guillaume NguyenSorbonne University, AP-HP, Laboratory of Haematology Armand-Trousseau Hospital Paris France.
Zoia MinchevaSorbonne University, AP-HP, Laboratory of Haematology Armand-Trousseau Hospital Paris France.
Bruno CopinSorbonne University, AP-HP, Service de Génétique et Embryologie Médicales Armand-Trousseau Hospital Paris France.
Boutheina BouslamaSorbonne University, AP-HP, Laboratory of Haematology Armand-Trousseau Hospital Paris France.
Guy LevergerSorbonne University, AP-HP, Paediatric Haematology and Oncology Department Armand-Trousseau Hospital Paris France.
Arnaud PetitSorbonne University, AP-HP, Paediatric Haematology and Oncology Department Armand-Trousseau Hospital Paris France.ORCID https://orcid.org/0000-0001-8363-1622
Rémi FavierSorbonne University, AP-HP, Laboratory of Haematology Armand-Trousseau Hospital Paris France.
Hélène LapillonneSorbonne University, AP-HP, Laboratory of Haematology Armand-Trousseau Hospital Paris France.
Hélène BoutrouxSorbonne University, AP-HP, Paediatric Haematology and Oncology Department Armand-Trousseau Hospital Paris France.
Sorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial platelet disorder with associated myeloid malignancy (FPD-MM; OMIM 601399) is related to germline

Indexed as

genetic predisposition to diseasehaematologic diseasesRUNX1

Identifiers

PMID36819173
PMCPMC9928638
OpenAlexW4308460708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.